SC

Stacie Canan

Fate Therapeutics (United States) US

34
Publications
663
Citations
9
H-Index
9
i10-Index
3.5
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

PARP inhibition in cancer therapy (11) Trypanosoma species research and implications (6) PI3K/AKT/mTOR signaling in cancer (6) Research on Leishmaniasis Studies (5) Cancer therapeutics and mechanisms (4)

Affiliations

Bristol-Myers Squibb (Germany)
DE 2024 - 2024
Pfizer (United States)
US 2007 - 2007
Bristol-Myers Squibb (United States)
US 2024 - 2021
Loxo Oncology at Lilly (United States)
US 2020 - 2020
Fate Therapeutics (United States)
US 2026 - 2026

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now